Company Synaptogenix, Inc. Other OTC
Equities
SNPX
US87167T1025
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 13-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 17-12-31 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 16-11-13 |
Joshua Silverman
CHM | Chairman | 53 | 16-08-03 |
Director/Board Member | 50 | 18-12-12 | |
William Singer
BRD | Director/Board Member | 82 | 13-08-22 |
Daniel Alkon
PSD | President | 81 | 20-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,233,230 | 1,206,807 ( 97.86 %) | 0 | 97.86 % |
Stock B | 0 | 3,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |